# 바이오스페이스 일일 뉴스 리포트 - 2025년 10월 01일


## 주요 헤드라인

1. **Pfizer To Offer Drugs at a Discount in Agreement with US Government (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/pfizer-to-offer-drugs-at-a-discount-in-agreement-with-us-government>

2. **Pfizer To Offer Drugs at a Discount in Agreement with US Government (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/pfizer-to-offer-drugs-at-a-discount-in-agreement-with-us-government>

3. **FDA Delays Likely as Federal Government Hurtles Toward Shutdown (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/fda-delays-likely-as-federal-government-hurtles-toward-shutdown>

4. **FDA Delays Likely as Federal Government Hurtles Toward Shutdown (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/fda-delays-likely-as-federal-government-hurtles-toward-shutdown>

5. **Sutro Makes Deeper Cuts To Extend Runway Into 2027, Reach Key Data Readout (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sutro-makes-deeper-cuts-to-extend-runway-into-2027-reach-key-data-readout>

6. **Sutro Makes Deeper Cuts To Extend Runway Into 2027, Reach Key Data Readout (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sutro-makes-deeper-cuts-to-extend-runway-into-2027-reach-key-data-readout>

7. **Metsera’s Obesity Drug Shows ‘Very Encouraging’ Mid-Stage Efficacy, Supporting Pfizer’s $4.9B Bet (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/metseras-obesity-drug-shows-very-encouraging-mid-stage-efficacy-supporting-pfizers-4-9b-bet>


---
*2025년 10월 01일 바이오스페이스 뉴스 피드에서 생성된 리포트*